Evidence map›Paper›PMID 40662073›Full record

ArticleFrontiers in medicine2025

Machine learning-enabled prediction of bone metastasis in esophageal cancer.

Liqiang Liu, Wanshi Duan, Tao She, Shouzheng Ma, Haihui Wang, Jiakuan Chen

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liqiang LiuTangdu Hospital, Fourth Military Medical University, Xi'an, China.
Wanshi DuanTangdu Hospital, Fourth Military Medical University, Xi'an, China.
Tao SheTangdu Hospital, Fourth Military Medical University, Xi'an, China.
Shouzheng MaTangdu Hospital, Fourth Military Medical University, Xi'an, China.
Haihui WangAir Force Medical University, Xi'an, China.
Jiakuan ChenTangdu Hospital, Fourth Military Medical University, Xi'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Bone metastasis (BM) is a common manifestation of distant spread in patients with esophageal cancer. This study aimed to develop a machine learning algorithm to predict the risk of bone metastasis in esophageal cancer patients, thereby supporting clinical decision-making support. Methods: Clinical and pathological data of esophageal cancer patients were obtained from the SEER database of the U.S. National Institutes of Health from 2010 to 2020. Six machine learning models were constructed: Support Vector Machine, Logistic Regression, Extreme Gradient Boosting, Neural Network, Random Forest, and k-Nearest Neighbors. Models performance was evaluated using accuracy, precision, recall, F1-score, and the area under the receiver operating characteristic curve. The optimal model was further used to interpret the associations between clinicopathological features and bone metastasis. Results: A total of 9,744 patients were included, with 532 (5.47%) had bone metastasis and 9,212 (94.53%) without. Multivariate logistic regression analysis identified age, T stage, N stage, and histological type as independent risk factors for bone metastasis. The XGBoost model demonstrated the best performance, achieving an accuracy of 0.80, a recall of 0.99, a precision of 0.72, an F1-score of 0.8300, and AUC of 0.92. Conclusion: The XGBoost model showed excellent predictive performance for bone metastasis in esophageal cancer patients, providing valuable insights for guiding clinical treatment decisions.

Indexed as

bone metastasisesophageal cancermachine learningprediction modelXGBoost

Identifiers

PMID40662073
PMCPMC12256537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.